AU648899B2 - Controlled release tablet containing water soluble medicament - Google Patents

Controlled release tablet containing water soluble medicament

Info

Publication number
AU648899B2
AU648899B2 AU18224/92A AU1822492A AU648899B2 AU 648899 B2 AU648899 B2 AU 648899B2 AU 18224/92 A AU18224/92 A AU 18224/92A AU 1822492 A AU1822492 A AU 1822492A AU 648899 B2 AU648899 B2 AU 648899B2
Authority
AU
Australia
Prior art keywords
water soluble
controlled release
containing water
release tablet
tablet containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU18224/92A
Other versions
AU1822492A (en
Inventor
Kenneth L. Evenstad
Kuldip R. Malhotra
Victoria A. O'neill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kos Pharmaceuticals Inc
Original Assignee
Upsher Smith Laboratories LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/536,184 priority Critical patent/US5126145A/en
Priority to JP01688392A priority patent/JP3778948B2/en
Application filed by Upsher Smith Laboratories LLC filed Critical Upsher Smith Laboratories LLC
Priority to AU18224/92A priority patent/AU648899B2/en
Priority to US07/905,785 priority patent/US5268181A/en
Publication of AU1822492A publication Critical patent/AU1822492A/en
Application granted granted Critical
Publication of AU648899B2 publication Critical patent/AU648899B2/en
Assigned to KOS PHARMACEUTICALS, INCORPORATED reassignment KOS PHARMACEUTICALS, INCORPORATED Alteration of Name(s) in Register under S187 Assignors: UPSHER-SMITH LABORATORIES, INC.
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU18224/92A 1989-04-13 1992-06-15 Controlled release tablet containing water soluble medicament Expired AU648899B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US07/536,184 US5126145A (en) 1989-04-13 1990-06-11 Controlled release tablet containing water soluble medicament
JP01688392A JP3778948B2 (en) 1989-04-13 1992-01-31 Controlled release tablets containing water soluble drugs
AU18224/92A AU648899B2 (en) 1989-04-13 1992-06-15 Controlled release tablet containing water soluble medicament
US07/905,785 US5268181A (en) 1989-04-13 1992-06-29 Method of using niacin to control nocturnal cholesterol synthesis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33746089A 1989-04-13 1989-04-13
AU18224/92A AU648899B2 (en) 1989-04-13 1992-06-15 Controlled release tablet containing water soluble medicament

Publications (2)

Publication Number Publication Date
AU1822492A AU1822492A (en) 1993-12-23
AU648899B2 true AU648899B2 (en) 1994-05-05

Family

ID=25617078

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18224/92A Expired AU648899B2 (en) 1989-04-13 1992-06-15 Controlled release tablet containing water soluble medicament

Country Status (1)

Country Link
AU (1) AU648899B2 (en)

Also Published As

Publication number Publication date
AU1822492A (en) 1993-12-23

Similar Documents

Publication Publication Date Title
GB2218905B (en) Controlled release pharmaceutical
AU622526B2 (en) Sustained release pharmaceutical preparation
AU6203386A (en) Controlled release tablet
AU589866B2 (en) Sustained release capsule
AU6893287A (en) Sustained release pharmaceutical preparation
AU558500B2 (en) Controlled slow release tablet
AU5434190A (en) Tablet dispenser
AU1828988A (en) Controlled release formulation
EP0251459A3 (en) Controlled release pharmaceutical composition
AU2707788A (en) Sustained release pharmaceutical composition
AU546249B2 (en) Slow release tablet formulation
AU6820787A (en) Sustained release capsule or tablet formulation
AU623209B2 (en) Theophylline dosage form
AU1174388A (en) Sustained release dosage forms
AU7141087A (en) Pharmaceutical slow release tablets of etorphine
AU4174685A (en) Drug release device
AU4918790A (en) Medicament
GB2190287B (en) Controlled release ketoprofen pharmaceutical formulation
AU3041789A (en) Pharmaceutical formulations with controlled drug release
AU648899B2 (en) Controlled release tablet containing water soluble medicament
AU4758190A (en) Pharmaceutical preparation
AU3992289A (en) Intrauterine catheter
AU634400C (en) Controlled release pharmaceutical preparation
IE862306L (en) Controlled release tablet
AU3595989A (en) Ph-dependent drug release composition

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: KOS PHARMACEUTICALS, INC.

Free format text: FORMER OWNER WAS: UPSHER-SMITH LABORATORIES, INC.